Migdal Insurance & Financial Holdings Ltd. Has $2.35 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Migdal Insurance & Financial Holdings Ltd. grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 181.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 4,467 shares of the healthcare conglomerate’s stock after purchasing an additional 2,880 shares during the period. Migdal Insurance & Financial Holdings Ltd.’s holdings in UnitedHealth Group were worth $2,346,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in the company. KLCM Advisors Inc. raised its holdings in UnitedHealth Group by 42.5% during the fourth quarter. KLCM Advisors Inc. now owns 4,010 shares of the healthcare conglomerate’s stock worth $2,111,000 after buying an additional 1,196 shares during the last quarter. Rakuten Securities Inc. bought a new position in UnitedHealth Group in the 4th quarter valued at about $153,000. Guidance Capital Inc. increased its holdings in UnitedHealth Group by 8.0% during the 4th quarter. Guidance Capital Inc. now owns 1,681 shares of the healthcare conglomerate’s stock worth $907,000 after purchasing an additional 124 shares in the last quarter. Sfmg LLC lifted its holdings in shares of UnitedHealth Group by 4.3% in the fourth quarter. Sfmg LLC now owns 1,464 shares of the healthcare conglomerate’s stock valued at $771,000 after purchasing an additional 61 shares in the last quarter. Finally, TRUE Private Wealth Advisors grew its holdings in UnitedHealth Group by 10.5% during the fourth quarter. TRUE Private Wealth Advisors now owns 2,091 shares of the healthcare conglomerate’s stock worth $1,101,000 after buying an additional 198 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $478.99 on Thursday. The firm’s 50 day moving average is $489.51 and its 200 day moving average is $515.38. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $554.70. The stock has a market capitalization of $441.60 billion, a P/E ratio of 29.28, a PEG ratio of 1.28 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The company had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same period in the previous year, the company posted $6.26 EPS. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.75 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a yield of 1.57%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is 45.97%.

Analyst Ratings Changes

UNH has been the topic of a number of analyst reports. Barclays lifted their price objective on shares of UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a report on Wednesday. TD Cowen reduced their price objective on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a research report on Wednesday, April 10th. Royal Bank of Canada cut their target price on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research note on Wednesday. Oppenheimer reiterated an “outperform” rating and set a $610.00 price target on shares of UnitedHealth Group in a report on Wednesday, January 17th. Finally, Truist Financial reaffirmed a “buy” rating and set a $600.00 target price on shares of UnitedHealth Group in a research report on Wednesday. Three investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $569.68.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.